Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 25, 2022

SELL
$57.43 - $71.39 $1.49 Million - $1.85 Million
-25,911 Closed
0 $0
Q4 2021

Jan 25, 2022

SELL
$63.4 - $87.14 $104,927 - $144,216
-1,655 Reduced 6.0%
25,911 $1.8 Million
Q3 2021

Oct 14, 2021

BUY
$69.28 - $84.46 $1.91 Million - $2.33 Million
27,566 New
27,566 $1.92 Million

Others Institutions Holding ATRC

About AtriCure, Inc.


  • Ticker ATRC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 46,424,700
  • Market Cap $1.04B
  • Description
  • AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...
More about ATRC
Track This Portfolio

Track Genesee Capital Advisors, LLC Portfolio

Follow Genesee Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Genesee Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Genesee Capital Advisors, LLC with notifications on news.